This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 4 CIPO patents and 3 EPO patents. Top assignees: Astrazeneca Ab, Kudos Pharmaceuticals Limited, Rigel Pharmaceuticals, Incorporated. Active years: 2010-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,534 
2 out of 36 
1 out of 492 
Years Active: 2010-2017
Title: Martin Francis Jones: Innovator in Pharmaceutical Processes
Introduction
Martin Francis Jones is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes and intermediates for drug manufacturing. With a total of 6 patents to his name, Jones has established himself as a key figure in pharmaceutical innovation.
Latest Patents
Among his latest patents, Jones has focused on a pharmaceutical process and intermediates. The present disclosure provides for processes and intermediates in the large-scale manufacture of the compound of formula (I) or hydrates thereof. This innovation is crucial for enhancing the efficiency and effectiveness of pharmaceutical production.
Career Highlights
Throughout his career, Martin Francis Jones has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Kudos Pharmaceuticals Limited and AstraZeneca. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking advancements in drug manufacturing.
Collaborations
Jones has collaborated with several professionals in his field, including Keith Allan Menear and Anthony Peter Ottridge. These collaborations have further enriched his work and have led to significant developments in pharmaceutical processes.
Conclusion
Martin Francis Jones is a distinguished inventor whose work in pharmaceutical processes has made a lasting impact on the industry. His innovative patents and collaborations highlight his commitment to advancing drug manufacturing techniques.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile